The global protein expression market is estimated to be worth USD 4253.54 million by 2032 and USD 2116 million by 2024, growing at a CAGR of 9.12% during the forecast period.
Protein expression can closely relate to gene expression as the proteins' blueprints are commonly stored in the DNA. This process involves transcribing DNA molecules to produce RNA and translating RNA to form a protein. When double-stranded DNA is unwounded, it allows us to bind RNA polymerase, initiating the transcription process. The translation process may start before completing the transcription process when a mature RNA molecule is released. The protein expression process's main aim is to generate specific proteins with high quality using living organisms.
An increasing number of research institutes in the life sciences sector is also accelerating market demand. The growing prevalence of effective treatment procedures is significantly influencing the market's growth. Growing incidences of chronic diseases worldwide are setting up growth opportunities for the market. Furthermore, increasing the adverse effects of molecular drugs are making people shift towards biologics, lavishing the demand of the global protein expression market.
However, the cost of installing and maintaining equipment in laboratories impedes the demand of the global protein expression market. The lack of skilled persons to analyze the final outputs inconvenient way also reduces the market's fastest growth. Lack of standardization is another attribute hampering the demand of the market.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2032 |
Base Year |
2023 |
Forecast Period |
2024 to 2032 |
Segments Covered |
By Expression Systems, Products, End-User, and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis; Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
Key Market Players |
Agilent Technologies, Life Technologies Corporation, Bio-Rad Laboratories, New England BioLabs, Merck Millipore, Takara Bio, Thermo Fisher Scientific, and Promega Corporation. |
The bacterial expression system segment is predicted to hold the largest share of the global protein expression market during the forecast period. In contrast, the mammalian expression system segment is projected to grow at the highest CAGR during the forecast period due to the increasing demand for therapeutic proteins essential for humane treatment.
The mammalian expression segment is projected to exhibit the highest growth rate during the forecast period by expression systems. The growth is due to the escalating popularity of the designs for biopharmaceuticals and research applications growing with profitable market growth over the analysis period.
The insect and cell expression are expected to perform well during the forecast period due to the growing focus on proteomics research, intensifying government support for research activities, and easy availability of advanced systems Bac-to-Bac expression system.
The reagents segment had the largest share of the worldwide market in 2023 and is expected to grow at a healthy CAGR during the forecast period owing to the increasing number of patients suffering from genetic diseases and the frequent purchase of reagents for various applications.
The services segment is to have the quickest growing rate during the forecast period due to the rising trend for characteristic optimization of protein expression. In addition, the service providers are prepared with advanced products and research specialists. These factors surge the demand for protein expression services by manufacturers and research laboratories.
The therapeutic protein segment has grown tremendously in recent years and is anticipated to hold the leading share of the global protein expression market during the forecast period owing to the rise in hospitals' construction activities with the latest equipment. In addition, therapeutic proteins provide high efficiency and quality in biologics manufacture and the increasing familiarity of therapeutic proteins over other drugs fuels the growth rate of the segment.
The research segment will grow with a profitable CAGR growth rate during the forecast period.
The biotechnology and pharmaceutical companies segment is expected to hold the largest revenue share in the protein expression market by end-user during the forecast period. The growth of the segment is primarily attributed to the increasing investments in drug discovery, design, and development.
North America is positioned top in holding a significant market share. The rise in capital income in developed and developing countries is ascribed to bolstering the market's demand. Also, an increased production rate of vaccines and antibodies in pharmaceutical companies will likely outshine the market's demand.
The Asia Pacific is next to North America, holding the largest shares of the market. Increasing acceptance of the latest technological developments and the launch of various products in favor of the end-users are leveraging its growth. Along with this, Changes in the government's schemes and the introduction of reimbursement policies that benefit ordinary people are gearing up the market demand.
Europe has had the fastest growth rate over recent years and will grow at a constant rate in the future. A growing number of infectious diseases and preferences for new developments in treatment procedures broaden the market demand in this region. Also, the rise in living standards with increased monthly income escalates the market's growth.
Latin America is to have substantial growth opportunities in the coming years. The growing geriatric population and rise in the number of diabetic patients are prompting the market's demand. In addition, the increasing scale of end-users such as dairy, food & beverages, chemical, and pharmaceutical industries across the region are gearing up the market's growth.
The rise in the demand to manufacture quality drugs with fewer or no side effects impacts the market's growth. The Middle East and Africa are anticipated to have a tremendous growth rate in the coming years. Increasing awareness of treatment procedures is propelling the demand of the market. In addition, the emergence of pharmaceuticals and biotechnologies fields in protein expression is leveling up the market's growth.
Companies playing a leading role in the global protein expression market include Agilent Technologies, Life Technologies Corporation, Bio-Rad Laboratories, New England BioLabs, Merck Millipore, Takara Bio, Thermo Fisher Scientific and Promega Corporation.
By Expression Systems
By-Products
By Application
By End-User
By Region
Frequently Asked Questions
The growing demand for biologics, the growing prevalence of chronic diseases, the increasing investment in research and development, and the need for more efficient and cost-effective protein production methods are majorly driving the growth of the protein expression market.
The high cost of protein production, the complex regulatory environment, the need for specialized expertise, and the potential for protein misfolding and aggregation are some of the major challenges to the protein expression market.
Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., Takara Bio Inc., and Qiagen N.V. are some of the notable companies in the protein expression market.
Emerging trends in the protein expression market include the use of gene editing technologies to improve protein production, the development of new expression systems, such as cell-free expression systems, and the integration of artificial intelligence and machine learning to optimize protein production.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region